Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Assistance Publique Hopitaux De Marseille.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT00769574
First received: October 8, 2008
Last updated: January 29, 2010
Last verified: January 2010
  Purpose

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).


Condition Intervention
Coronary Syndrome
Other: Biological analysis of biomarkers

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

Resource links provided by NLM:


Further study details as provided by Assistance Publique Hopitaux De Marseille:

Primary Outcome Measures:
  • To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS). [ Time Frame: 24 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Compare the characteristics of biological markers to those of usual or innovative markers [ Time Frame: 24 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: June 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Patients with coronary syndrome
Other: Biological analysis of biomarkers
Biological analysis of biomarkers
2
Subjects without coronary syndrome
Other: Biological analysis of biomarkers
Biological analysis of biomarkers

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • subjects over 18 years,
  • subject about having a chest pain of coronary syndrome,
  • subject about not having received heparin or LMWH

Exclusion Criteria:

  • subject minor
  • subject without informed consent,
  • subject after receiving an anticoagulant treatment,
  • transplanted heart, kidney or liver
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00769574

Contacts
Contact: Jean-Louis BONNET, MD 0491385974 jbonnet@mail.ap-hm.fr
Contact: Jean-Pierre AUFFRAY, MD 0491385816 jauffray@mail.ap-hm.fr

Locations
France
Hôpital de la Timone- Service cardiologie A Recruiting
Marseille, France, 13385
Contact: Jean-Louis BONNET, MD    0491385974    jbonnet@mail.ap-hm.fr   
Contact: Jean-Pierre AUFFRAY, MD    0491385816    jauffray@mail.ap-hm.fr   
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Principal Investigator: Jean-Louis BONNET, MD Assistance Publique des Hôpitaux de Marseille
  More Information

No publications provided

Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT00769574     History of Changes
Other Study ID Numbers: 2008-A00192-53
Study First Received: October 8, 2008
Last Updated: January 29, 2010
Health Authority: France: Ministry of Health

Additional relevant MeSH terms:
Chest Pain
Acute Coronary Syndrome
Pain
Signs and Symptoms
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Angina Pectoris
Vascular Diseases

ClinicalTrials.gov processed this record on August 19, 2014